Market Closed -
London S.E.
11:35:05 2024-05-28 am EDT
|
5-day change
|
1st Jan Change
|
59.3
GBX
|
+3.58%
|
|
-8.56%
|
-29.91%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,394
|
1,455
|
1,577
|
796.4
|
518.4
|
350.9
|
-
|
-
|
Enterprise Value (EV)
1 |
3,673
|
2,414
|
2,647
|
2,004
|
1,720
|
1,523
|
1,450
|
1,364
|
P/E ratio
|
17.1
x
|
-4.1
x
|
-15.3
x
|
-3.27
x
|
-2.8
x
|
15.7
x
|
6.17
x
|
4.93
x
|
Yield
|
3.48%
|
-
|
-
|
3.85%
|
2.01%
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.87
x
|
0.74
x
|
0.73
x
|
0.28
x
|
0.16
x
|
0.1
x
|
0.1
x
|
0.1
x
|
EV / Revenue
|
1.34
x
|
1.23
x
|
1.22
x
|
0.71
x
|
0.55
x
|
0.45
x
|
0.41
x
|
0.37
x
|
EV / EBITDA
|
7.2
x
|
12.9
x
|
8.82
x
|
4.79
x
|
4.46
x
|
3.66
x
|
3.15
x
|
2.73
x
|
EV / FCF
|
14.7
x
|
-7.74
x
|
-95.9
x
|
38.4
x
|
16.9
x
|
19.1
x
|
9.96
x
|
8.2
x
|
FCF Yield
|
6.79%
|
-12.9%
|
-1.04%
|
2.6%
|
5.92%
|
5.24%
|
10%
|
12.2%
|
Price to Book
|
2.23
x
|
0.95
x
|
1.12
x
|
0.59
x
|
-
|
0.42
x
|
0.29
x
|
0.29
x
|
Nbr of stocks (in thousands)
|
509,755
|
612,682
|
613,209
|
612,597
|
612,818
|
612,978
|
-
|
-
|
Reference price
2 |
4.696
|
2.374
|
2.572
|
1.300
|
0.8460
|
0.5725
|
0.5725
|
0.5725
|
Announcement Date
|
2/27/20
|
3/18/21
|
3/10/22
|
3/2/23
|
4/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,744
|
1,956
|
2,170
|
2,808
|
3,151
|
3,358
|
3,513
|
3,678
|
EBITDA
1 |
510.1
|
186.6
|
300
|
418.1
|
386
|
415.9
|
459.8
|
500.1
|
EBIT
1 |
295.3
|
-50.8
|
87
|
197.3
|
168.6
|
190.8
|
235.7
|
269.8
|
Operating Margin
|
10.76%
|
-2.6%
|
4.01%
|
7.03%
|
5.35%
|
5.68%
|
6.71%
|
7.34%
|
Earnings before Tax (EBT)
1 |
187
|
-444.7
|
-84.9
|
-209.9
|
-98.3
|
72.48
|
115.8
|
142.6
|
Net income
1 |
141.1
|
-331.7
|
-81.6
|
-221.8
|
-163.8
|
42.64
|
78.59
|
92.65
|
Net margin
|
5.14%
|
-16.96%
|
-3.76%
|
-7.9%
|
-5.2%
|
1.27%
|
2.24%
|
2.52%
|
EPS
2 |
0.2750
|
-0.5790
|
-0.1680
|
-0.3970
|
-0.3020
|
0.0365
|
0.0928
|
0.1161
|
Free Cash Flow
1 |
249.4
|
-312
|
-27.6
|
52.2
|
101.8
|
79.84
|
145.5
|
166.4
|
FCF margin
|
9.09%
|
-15.95%
|
-1.27%
|
1.86%
|
3.23%
|
2.38%
|
4.14%
|
4.52%
|
FCF Conversion (EBITDA)
|
48.89%
|
-
|
-
|
12.49%
|
26.37%
|
19.2%
|
31.64%
|
33.27%
|
FCF Conversion (Net income)
|
176.75%
|
-
|
-
|
-
|
-
|
187.26%
|
185.15%
|
179.59%
|
Dividend per Share
2 |
0.1635
|
-
|
-
|
0.0500
|
0.0170
|
-
|
-
|
-
|
Announcement Date
|
2/27/20
|
3/18/21
|
3/10/22
|
3/2/23
|
4/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2021 S1
|
2022 S1
|
2023 S1
|
---|
Net sales
1 |
1,032
|
992.4
|
1,324
|
1,569
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
|
-30.6
|
-26.1
|
90.5
|
-
|
Operating Margin
|
-2.97%
|
-2.63%
|
6.83%
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
Net income
1 |
-
|
-
|
-
|
-40.6
|
Net margin
|
-
|
-
|
-
|
-2.59%
|
EPS
2 |
-
|
-
|
-
|
-8.300
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/13/20
|
7/29/21
|
7/28/22
|
7/27/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,279
|
960
|
1,070
|
1,208
|
1,202
|
1,173
|
1,099
|
1,013
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.508
x
|
5.142
x
|
3.566
x
|
2.889
x
|
3.113
x
|
2.82
x
|
2.389
x
|
2.026
x
|
Free Cash Flow
1 |
249
|
-312
|
-27.6
|
52.2
|
102
|
79.8
|
146
|
166
|
ROE (net income / shareholders' equity)
|
15.7%
|
-6.54%
|
1.52%
|
1.87%
|
-
|
6.24%
|
9.99%
|
10.3%
|
ROA (Net income/ Total Assets)
|
4.44%
|
-1.87%
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
3,177
|
17,753
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
2.100
|
2.490
|
2.300
|
2.200
|
-
|
1.360
|
1.980
|
2.000
|
Cash Flow per Share
2 |
0.6900
|
-0.1700
|
0.2800
|
0.3600
|
0.3700
|
0.5300
|
0.5500
|
0.6400
|
Capex
1 |
117
|
215
|
169
|
169
|
128
|
177
|
214
|
211
|
Capex / Sales
|
4.25%
|
11.01%
|
7.76%
|
6.02%
|
4.07%
|
5.28%
|
6.08%
|
5.74%
|
Announcement Date
|
2/27/20
|
3/18/21
|
3/10/22
|
3/2/23
|
4/22/24
|
-
|
-
|
-
|
Last Close Price
0.5725
GBP Average target price
0.85
GBP Spread / Average Target +48.47% Consensus |